LiliumX

LiliumX develops and uses an assembly platform which combines known protein and antibody components into bispecifics, then tests them for improved or novel drug candidates. Traditional antibodies bind to a single cellular target, but bispecifics can bring together and bind to two unique targets, which can, for example,

LiliumX is a company in health.

Profile

LiliumX develops and uses an assembly platform which combines known protein and antibody components into bispecifics, then tests them for improved or novel drug candidates. Traditional antibodies bind to a single cellular target, but bispecifics can bring together and bind to two unique targets, which can, for example, kill cancer cells. LiliumX’s platform enables the […]

Within the health space, the company focuses on its core offering rather than a broad product line.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: www.liliumx.com